CGRW Cannagrow Holdings Inc (PK)

ChromoCure, Inc. (PINKSHEETS: KKUR) announced today that it will be breaking ground on its new facility in Florida at some point in the first quarter of 2010.

ChromoCure's technology is believed to detect cancer even at its most early stages with 100% accuracy. The new diagnostic center will be open for pathologists and researchers to come in and explore ChromoCure's technology.

The center will receive a ChromoCure CS200 to train and educate its pathology partners on site. By increasing the amount of labs using the CS200, ChromoCure hopes to not only to be able to detect all cancers at any stage in the human body, but also engineer its eventual cure.

More of ChromoCure's initiatives will be announced ahead of the scheduled opening of its facility.

For more information, please visit www.chromocure.com.

Other active stocks are Cardinal Health Inc. (NYSE: CAH), Xtend Medical Corp. (PINKSHEETS: XMDC) and BizAuctions (PINKSHEETS: BZCN).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact: Eric Jensen www.ionewswire.com 516.942.4910